Entrada Therapeutics, Inc. (TRDA)

NASDAQ: TRDA · Real-Time Price · USD

7.67

+0.63 (8.95%)

Aug 12, 2026, 4:00 PM EDT - Market closed

Entrada Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	277	394	650	505	424	535
Market Cap Growth	49.88%	-39.42%	28.76%	18.87%	-20.60%	-
Enterprise Value	102.1	148.8	288.87	220.83	261.68	243.5
Last Close Price	7.67	10.28	17.29	15.09	13.52	17.12

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	10.29	-	-	-
PS Ratio	59.02	15.48	3.08	3.91	-	-
PB Ratio	1.18	1.29	1.52	2.08	2.00	1.79
P/TBV Ratio	1.37	1.39	1.57	2.06	1.99	0.36
P/FCF Ratio	-	-	-	3.76	-	-
P/OCF Ratio	-	-	-	3.61	-	-

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	21.79	5.85	1.37	1.71	-	-
EV/EBITDA Ratio	-	-	5.69	-	-	-
EV/EBIT Ratio	-	-	6.14	-	-	-
EV/FCF Ratio	-	-	-	1.65	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.19	0.15	0.12	0.25	0.08	0
Debt / EBITDA Ratio	-	-	1.17	-	-	-
Debt / FCF Ratio	-	-	-	0.51	-	-
Net Debt / Equity Ratio	-0.75	-0.80	-0.84	-1.17	-0.77	-0.97
Net Debt / EBITDA Ratio	1.01	1.59	-7.10	883.92	1.71	5.82
Net Debt / FCF Ratio	1.30	1.89	8.07	-2.11	1.68	5.25
Asset Turnover	0.01	0.06	0.42	0.36	0	0
Quick Ratio	10.47	12.14	10.73	2.25	8.59	43.32
Current Ratio	10.89	12.53	11.15	2.33	9.55	44.46
Return on Equity (ROE)	-61.45%	-39.13%	19.56%	13.54%	-37.01%	-30.19%
Return on Assets (ROA)	-52.47%	-35.17%	9.32%	-2.24%	-34.86%	-29.27%
Return on Invested Capital (ROIC)	-284.54%	-245.90%	350.11%	-192.34%	-338.65%	-1165.02%
Return on Capital Employed (ROCE)	-56.00%	-37.61%	11.79%	-1.17%	-36.75%	-30.14%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-	-	9.72%	-	-	-
FCF Yield	-	-	-	26.59%	-	-
Buyback Yield / Dilution	-1.93%	-6.07%	-18.01%	-5.61%	-399.27%	-467.09%
Total Shareholder Return	-1.93%	-6.07%	-18.01%	-5.61%	-399.27%	-467.09%

SEC Filings: 10-K · 10-Q